Sanguine Biosciences, Inc.

Sanguine Biosciences accelerates personalized medicine and biomedical research by connecting patients with pharmaceutical and biotechnology researchers. Its direct-to-donor model collects high-quality disease-state and healthy biospecimens, including blood products and cells, alongside comprehensive donor health data. The company supports translational, clinical, therapeutic, diagnostic, and cell-and-gene-therapy research, helping partners improve study quality, validate results, and advance promising programs toward clinical trials more quickly.